bio-biloba -
pharma nord aps produktion - ginkgoblad - tablett, filmdrasjert
navirel 10 mg/ ml
medac gesellschaft für klinische spezialpräparate mbh - vinorelbintartrat - konsentrat til infusjonsvæske, oppløsning - 10 mg/ ml
phesgo
roche registration gmbh - pertuzumab, trastuzumab - bryst neoplasms - antineoplastiske midler - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.
epirubicin accord 2 mg/ ml
accord healthcare b.v. - epirubicinhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 2 mg/ ml
epirubicin actavis 2 mg/ ml
actavis group ptc ehf - epirubicinhydroklorid - injeksjonsvæske, oppløsning - 2 mg/ ml
epirubicin actavis 10 mg
actavis group ptc ehf - epirubicinhydroklorid - pulver til injeksjons-/infusjonsvæske, oppløsning - 10 mg
epirubicin actavis 50 mg
actavis group ptc ehf - epirubicinhydroklorid - pulver til injeksjons-/infusjonsvæske, oppløsning - 50 mg
epirubicin medac 2 mg/ ml
medac gesellschaft für klinische spezialpräparate mbh - epirubicinhydroklorid - injeksjonsvæske, oppløsning - 2 mg/ ml
glucosamin pharma nord 400 mg
pharma nord aps produktion - glukosaminsulfatkaliumklorid - kapsel, hard - 400 mg